Correlations of quality of life with adverse effects of medication, social support, course of illness, psychopathology, and demographic characteristics in patients with panic disorder

Depression and Anxiety

Volumn 24, Issue 8, 2007, Pages 563-570

  Yen, Cheng Fang ^a,b   Kuo, Chun Ya ^a   Tsai, Pei Tzu ^c   Ko, Chih Hung ^b   Yen, Ju Yu ^b,d   Chen, Tzu Ting ^e  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c Wong Group Practice Clinic   (Taiwan)

^d KAOHSIUNG MUNICIPAL HSIAO KANG HOSPITAL   (Taiwan)

^e YULI VETERANS HOSPITAL   (Taiwan)

Author keywords

Depression; Panic disorder; Quality of life; Social support

Indexed keywords

BENZODIAZEPINE; SEROTONIN UPTAKE INHIBITOR;

ADULT; AGED; AGORAPHOBIA; ANXIETY; ARTICLE; BECK DEPRESSION INVENTORY; CONTROLLED STUDY; CORRELATION ANALYSIS; DEPRESSION; DISEASE COURSE; DISEASE SEVERITY; DRUG EFFECT; FEMALE; HUMAN; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; PANIC; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; SOCIAL SUPPORT; UNSPECIFIED SIDE EFFECT; WORLD HEALTH ORGANIZATION;

ADULT; ANTIDEPRESSIVE AGENTS; DEMOGRAPHY; DISEASE PROGRESSION; FEMALE; HEALTH STATUS; HUMANS; MALE; PANIC DISORDER; QUALITY OF LIFE; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; SOCIAL SUPPORT; WORLD HEALTH ORGANIZATION;

EID: 37249075940     PISSN: 10914269     EISSN: 15206394     Source Type: Journal    
DOI: 10.1002/da.20239     Document Type: Article

References (54)

1. Albrecht GL, Fitzpatrick R. 1994. A sociological perspective on health-related quality of life research. In: Albrecht GL, Fitzpatrick R, editors. Advances in medical sociology: Vol. 5. Quality of life in health care. London: JAI Press, p 1-21.
2. American Psychiatric Association. 1994. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: Author.
3. Atkinson M, Zibin S, Chuang H. 1997. Characterizing quality of life among patients with chronic mental illness: A critical examination of the self-report methodology. Am J Psychiatry 154:99-105.
4. Ballenger JC, Burrows GD, DuPont RL Jr, Lesser IM, Noyes R Jr, Pecknold JC, Rifkin A, Swinson RP. 1988. Alprazolam in panic disorder and agoraphobia: Results from a multicenter trial: I. Efficacy in short-term treatment. Arch Gen Psychiatry 45:413-422.
5. Barrera M, Sandler I. 1981. Preliminary development of a scale of social support: Studies on college students. Am J Community Psychol 9:435-447.
6. Beck AT, Steer RA, Brown GK. 1996. Manual for the Beck Depression Inventory-II. San Antonio, TX: Psychological Corporation.
7. Buller R, Winter P, Amering M, Katschnig H, Lavori PW, Deltito JA, Klerman GL. 1992. Center differences and cross-national invariance in help-seeking for panic disorder: A report from the Cross-National Collaborative Panic Study. Soc Psychiatry Psychiatr Epidemiol 27:135-141.
8. Candilis PJ, McLean RY, Otto MW, Manfro GG, Worthington JJ III, Penava SJ, Marzol PC, Pollack MH. 1999. Quality of life in patients with panic disorder. J Nerv Ment Dis 187:429-434.
9. Carpiniello B, Baita A, Carta MG, Sitzia R, Macciardi AM, Murgia S, Altamura AC. 2002. Clinical and psychosocial outcome of patients affected by panic disorder with or without agoraphobia: Results from a naturalistic follow-up study. Eur Psychiatry 17:394-398.
10. Cramer V, Torgersen S, Kringlen E. 2005. Quality of life and anxiety disorders: A population study. J Nerv Ment Dis 193:196-202.
11. Doeglas DM, Suurmeijer TPBM, van den Heuvel WJA, Krol B, van Rijswijk MH, van Leeuwen MA, Sanderman R. 2004. Functional ability, social support, and depression in rheumatoid arthritis. Qual Life Res 13:1053-1065.
12. Edlund MJ, Swann AC. 1987. The economic and social costs of panic disorder. Hosp Community Psychiatry 38:1277-1279.
13. Ettigi P, Meyerhoff AS, Chirban JT, Jacobs RJ, Wilson RR. 1997. The quality of life and employment in panic disorder. J Nerv Ment Dis 185:368-372.
14. Fava GA, Rafanelli C, Ottolini F, Ruini C, Cazzaro M, Grandi S. 2001. Psychological well-being and residual symptoms in remitted patients with panic disorder and agoraphobia. J Affect Disord 65:185-190.
15. Fayers PM, Machin D. 2000. Quality of like: Assessment, analysis and interpretation. West Sussex, UK: Wiley.
16. Gorman J, Shear K, Cowley D, Cross CD, March J, Roth W, Shehi M, Wang PS. 2002. Treatment of patients with panic disorder. In: McIntyre JS, Charles SC, editors. Practice guidelines for the treatment of psychiatric disorders. Washington, DC: American Psychiatric Association. p 635-696.
17. Hansson L, Middelboe T, Merinder L, Bjarnason O, Bengtsson-Tops A, Nilsson L, Sandlund M, Sourander A, Sorgaard KW, Vinding H. 1999. Predictors of subjective quality of life in schizophrenic patients living in the community: A Nordic multicentre study. Int J Soc Psychiatry 45:247-158.
18. Hollifield M, Katon W, Skipper B, Chapman T, Ballenger JC, Mannuzza S, Fyer AJ. 1997. Panic disorder and quality of life: Variables predictive of functional impairment. Am J Psychiatry 154:766-772.
19. Jacobs RJ, Davidson JR, Gupta S, Meyerhoff AS. 1997. The effects of clonazepam on quality of life and work productivity in panic disorder. Am J Managed Care 3:1187-1196.
20. Jaracz K, Kozubski W. 2003. Quality of life in stroke patients. Acta Neurol Scand 107:324-329.
21. Katerndahl DA. 2001. Community correlates of outcomes in subjects with panic attacks. Depress Anxiety 13:194-197.
22. Katerndahl DA, Realini JP. 1997. Quality of life and panic-related work disability in subjects with infrequent panic and panic disorder. J Clin Psychiatry 58:153-158.
23. Katschnig H. 1997. How useful is the concept of quality of life in psychiatry. In: Katschnig H, Freeman H, Sartorius N, editors. Quality of life in mental disorders. West Sussex, UK: Wiley. p 3-16.
24. Keller MB, Hanks DL. 1993. Course and outcome in panic disorder. Biol Psychiatry 17:551-570.
25. Koivumaa-Honkanen HT, Viinamaki H, Honkanen R, Tanskanen A, Antikainen R, Niskanen L, Jaaskelainen J, Lehtonen J. 1996. Correlates of life satisfaction among psychiatric patients. Acta Psychiatr Scand 94:372-378.
26. Lochner C, Mogotsi M, du Toit PL, Kaminer D, Niehaus DJ, Stein DJ. 2003. Quality of life in anxiety disorders: A comparison of obsessive-compulsive disorder, social anxiety disorder, and panic disorder. Psychopathology 36:255-262.
27. Lu ML, Che HH, Chang SW, Shen WW. 2002. Reliability and validity of the Chinese version of the Beck Depression Inventory-II. Taiwanese J Psychiatry 16:301-310.
28. Markowitz JS, Weissman MM, Ouellette R, Lish JD, Klerman GL. 1989. Quality of life in panic disorder. Arch Gen Psychiatry 46:984-992.
29. Massion AO, Warshaw MG, Keller MB. 1993. Quality of life and psychiatric morbidity in panic disorder and generalized anxiety disorder. Am J Psychiatry 150:600-607.
30. Michael Kaplan E, DuPont RL. 2005. Benzodiazepines and anxiety disorders: A review for the practicing physician. Curr Med Res Opin 21:941-950.
31. Nesse RM, Zamorski MA. 1997. Anxiety disorders in primary care. In: Knespar DJ, Riba MB, Schwenk TL, editors. Primary care psychiatry. Philadelphia: Saunders. p 132-162.
32. Noyes R Jr, Clancy J, Woodman C, Holt CS, Suelzer M, Christiansen J, Anderson DJ. 1993. Environmental factors related to the outcome of panic disorder: A seven-year follow-up study. J Nerv Ment Dis 181:529-538.
33. Noyes R Jr, DuPont RL Jr, Pecknold JC, Rifkin A, Rubin RT, Swinson RP, Ballenger JC, Burrows GD. 1988. Alprazolam in panic disorder and agoraphobia: Results from a multicenter trial: II. Patient acceptance, side effects, and safety. Arch Gen Psychiatry 45:423-428.
34. Rapaport MH, Pollack M, Wolkow R, Mardekian J, Clary C. 2000. Is placebo response the same as drug response in panic disorder? Am J Psychiatry 157:1014-1016.
35. Rin H, Schooler C, Caudill WA. 1973. Symptomatology and hospitalization: Culture, social structure and psychopathology in Taiwan and Japan. J Nerv Ment Dis 157:296-312.
36. Rubin HC, Rapaport MH, Levine B, Gladsjo JK, Rabin A, Auerbach M, Judd LL, Kaplan R. 2000. Quality of well-being in panic disorder: The assessment of psychiatric and general disability. J Affect Disord 57:217-221.
37. Schonfeld WH, Verboncoeur CJ, Fifer SK, Lipschutz RC, Lubeck DP, Buesching DP. 1997. The functioning and well-being of patients with unrecognized anxiety disorders and major depressive disorder. J Affect Disord 43:105-119.
38. Shapiro S, Skinner EA, Kessler LG, Von Korff M, German PS, Tischler GL, Leaf PJ, Benham L, Cottler L, Regier DA. 1984. Utilization of health and mental health services: Three Epidemiologic Catchment Area sites. Arch Gen Psychiatry 41:971-978.
39. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, Hergueta T, Baker R, Dunbar GC. 1998. The Mini-International Neuropsychiatric Interview (MINI): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 59(Suppl 20):34-57.
40. Sherbourne CD, Wells KB, Judd LL. 1996. Functioning and well-being of patients with panic disorder. Am J Psychiatry 153:213-218.
41. Shumaker SA, Ellis S, Naughton M. 1997. Assessing health-related quality of life in HIV disease: Key measurement issues. Qual Life Res 6:475-480.
42. Simon NM, Otto MW, Korbly NB, Peters PM, Nicolaou DC, Pollack MH. 2002. Quality of life in social anxiety disorder compared with panic disorder and the general population. Psychiatr Serv 53:714-718.
43. Stahl SM. 2002. Independent actions on fear circuits may lead to therapeutic synergy for anxiety when combining serotonergic and GABAergic agents. J Clin Psychiatry 63:854-855.
44. Stahl SM, Gergel I, Li D. 2003. Escitalopram in the treatment of panic disorder: A randomized, double-blind, placebo-controlled trial. J Clin Psychiatry 64:1322-1327.
45. Stastney P, Amering M. 1997. Integrating consumer perspectives on quality of life in research and service planning. In: Katschnig H, Freeman H, Sartorius N, editors. Quality of life in mental disorders. West Sussex, UK: Wiley. p 261-269.
46. Stewart SA. 2005. The effects of benzodiazepines on cognition. J Clin Psychiatry 66(Suppl 2):9-13.
47. Taylor D, Paton C, Kerwin R. 2005. The south London and Maudsley NHS Trust and Oxleas NHS Trust: 2005-2006 prescribing guidelines. London: Taylor and Francis. p 135-204.
48. Telch MJ, Schmidt NB, Jaimez TL, Jacquin KM, Harrington PJ. 1995. Impact of cognitive-behavioral treatment on quality of life in panic disorder patients. J Consult Clin Psychol 63:823-830.
49. WHOQOL Group. 1998. Development of the World Health Organization WHOQOL-BREF quality of life assessment. Psychol Med 28:551-558.
50. Wang YH. 1999. Study on life quality and its associated factors of rheumatoid arthritis patients. J Chang Gung Inst Technol 2:108-120.
51. Weissman MM. 1991. Panic disorder: Impact on quality of life. J Clin Psychiatry 52(Suppl 2):6-9.
52. Yanos PT, Rosenfield S, Horwitz AV. 2001. Negative and supportive social interactions and quality of life among persons diagnosed with severe mental illness. Community Ment Health J 37:405-419.
53. Yao G, Chung CW, Yu CF, Wang JD. 2002. Development and verification of validity and reliability of the WHOQOL-BREF Taiwan version. J Formos Med Assoc 101:342-351.
54. Yen CF, Tsai JJ, Lu PL, Chen YH, Chen TC, Chen PP, Chen TP. 2004. Quality of life and its correlates in HIV/AIDS male outpatients receiving highly active antiretroviral therapy in Taiwan. Psychiatry Clin Neurosci 58:501-506.